Protagonist Therapeutics, Inc.
PTGX
$44.27
-$1.00-2.21%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 78.02% | 22.63% | 46.13% | 79.96% | 39.81% |
| Total Receivables | -90.98% | 1,530.76% | 4,006.15% | 2,640.00% | 588,925.49% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -2.28% | 16.81% | 32.32% | 59.26% | -8.34% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -3.46% | 66.39% | 46.75% | 80.14% | 166.21% |
|
|
|||||
| Total Current Assets | -3.46% | 66.39% | 46.75% | 80.14% | 166.21% |
| Net Property, Plant & Equipment | 736.45% | 486.64% | 320.62% | 264.61% | -61.56% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Assets | 17.93% | 108.05% | 82.98% | 91.79% | 162.35% |
|
|
|||||
| Total Accounts Payable | -16.82% | 109.20% | 143.53% | -20.64% | -12.78% |
| Total Accrued Expenses | -29.09% | 22.64% | -16.40% | -21.56% | 1.19% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 239.39% | -55.30% | -97.50% | -- | -82.22% |
| Total Finance Division Other Current Liabilities | -2.71% | 21,129.41% | 14,093.20% | 12,977.71% | 5,375.84% |
| Total Other Current Liabilities | -2.71% | 21,129.41% | 14,093.20% | 12,977.71% | 5,375.84% |
| Total Current Liabilities | -12.02% | 122.80% | 59.97% | 57.50% | 71.81% |
|
|
|||||
| Total Current Liabilities | -12.02% | 122.80% | 59.97% | 57.50% | 71.81% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -71.73% | -- | -- | -- | -- |
| Total Liabilities | -22.88% | 226.36% | 158.16% | 177.69% | 190.54% |
|
|
|||||
| Common Stock & APIC | 7.44% | 6.66% | 6.07% | 8.56% | 23.17% |
| Retained Earnings | 13.76% | 44.69% | 26.57% | 27.91% | 28.42% |
| Treasury Stock & Other | 137.12% | 21.90% | 885.88% | -25.76% | -87.70% |
| Total Common Equity | 22.95% | 100.58% | 76.04% | 84.08% | 159.26% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 22.95% | 100.58% | 76.04% | 84.08% | 159.26% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 22.95% | 100.58% | 76.04% | 84.08% | 159.26% |
|
|
|||||